Research is the KEY

MJ's Army raises funds to give to current research efforts.

ALSTDI (Therapy Development Institute) is a great organization and is a constant recipient of funds from MJ's Army.

What makes ALSTDI so different from other biotech companies and research labs?
Our unique and comprehensive approach leverages more than a decade of treatment-focused ALS research and applies it on an industrial scale to get therapeutics to today’s ALS patients as quickly, efficiently, and cost-effectively as possible. Our research team evaluates the most promising therapeutic hypotheses through the lenses of the richest ALS research databases in the world.
Treatments of all kinds are considered and tested rigorously and rapidly. Dr. Steve Perrin, CEO frequently speaks about our research plan to patients, families, industry executives and academics worldwide.

Click here to Read more about ALS TDI's research plan.
For ALSTDI FAQ's go here.

If you don’t find the answers you need here, feel free to ask us your question.

---

Putting Patients First

The National ALS Association is an organization that supports ALS patients, their families and the most promising research.



The Leader in Global ALS Research The ALS Association has committed more than $67 million to find effective treatments and a cure for Lou Gehrig’s Disease. Our global research effort has helped increase the number of scientists working on ALS, advanced new discoveries and treatments, and has shed light on the complex genetic and environmental factors involved in ALS.  

The ALS Association has funded significant research milestones in the fight against ALS, including:

• The groundbreaking discovery of a genetic abnormality that is, to date, the most common cause known of ALS and FTD.
• The recent exciting finding involved in familial ALS shows how two proteins work together to buttress the survival of motor neurons.
• Discovery of the ALS gene, SOD1, responsible for 20 percent of all inherited ALS cases.
• Discovery of ALS6 in 2009, a new gene responsible for about 5% of all inherited ALS cases.
• The first clinical trial of ISIS-SOD1, a new drug that specifically targets the SOD1 gene.

---

MJ's Army - Foundation Fighting ALS

MJ's Army raises money specifically to help fight ALS. These funds are distributed at the direction of the board. Today these funds are split evenly between two worthy organizations. They are ALSTDI - ALS Therapy Development Institute and the ALS Association - Fighting Lou Gehrig's Disease. Please read on to learn more about these benevolent organizations doing the urgent work required in the ALS Community.